Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,19916,805,1.14 [0.97-1.34],0.1092146651850163
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,19301,236,1.34 [1.01-1.79],0.0449699297570467
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,22078,141,1.20 [0.83-1.74],0.331177166949145
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,14887,802,1.20 [1.02-1.41],0.0304185187054742
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,22037,100,1.14 [0.73-1.79],0.5559550466438842
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,20007,89,1.05 [0.64-1.71],0.8599452859354377
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",23073,99,1.17 [0.75-1.83],0.4960238626904385
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,23083,67,1.02 [0.58-1.79],0.943495840323956
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,19588,52,1.47 [0.84-2.56],0.1804887016526677
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,22108,117,1.02 [0.66-1.55],0.9410006587016134
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Other septicaemia,22074,83,1.10 [0.67-1.80],0.7076277814082532
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,23159,59,1.14 [0.65-2.03],0.645880439239641
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Other viral diseases,23183,60,1.01 [0.56-1.83],0.9651633502436868
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",23176,53,0.86 [0.45-1.66],0.6618524226257706
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Mycoses,22849,41,0.87 [0.41-1.82],0.7029540687982485
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",21926,380,1.35 [1.09-1.68],0.006564403943873
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,21695,149,1.13 [0.78-1.62],0.5229865018891067
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,21804,258,1.52 [1.18-1.95],0.0010947228152365
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)",18116,77,1.21 [0.73-2.02],0.4567228453141505
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",18087,48,1.49 [0.81-2.75],0.1966806686122983
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",18302,263,1.25 [0.95-1.65],0.1170007515240849
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",18309,270,1.25 [0.95-1.65],0.1076615207256971
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",18267,228,1.15 [0.85-1.56],0.3598012287185173
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",18092,53,1.48 [0.83-2.62],0.1836193053318
CEBPB,CCAAT/enhancer-binding protein beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,20588,540,1.15 [0.95-1.40],0.1636154708796156
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",21703,364,0.91 [0.71-1.16],0.4317704894359221
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,22594,126,0.97 [0.64-1.46],0.8799537066465128
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",23219,126,0.92 [0.61-1.40],0.6970639178694464
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Benign neoplasm: Rectum,22890,73,0.82 [0.47-1.44],0.4930173865799693
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,23237,66,0.96 [0.54-1.70],0.8795844070936559
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Benign neoplasm: Stomach,23281,48,0.81 [0.40-1.63],0.5536616115118602
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Benign lipomatous neoplasm,22967,313,0.96 [0.73-1.25],0.7440188285062476
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,23249,107,0.96 [0.61-1.51],0.8714223199835435
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,23254,72,0.61 [0.34-1.11],0.1047819371419148
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",23204,34,0.72 [0.31-1.66],0.4345475753052489
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Haemangioma, any site",23207,34,0.72 [0.31-1.66],0.4345832347371406
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Melanocytic naevi,23136,127,0.90 [0.59-1.37],0.628077349630935
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Melanocytic naevi of other and unspecified parts of face,23262,53,0.68 [0.34-1.34],0.2657261339207717
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Other benign neoplasms of skin,23167,132,0.99 [0.66-1.48],0.9524872273717956
CEBPB,CCAAT/enhancer-binding protein beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,22108,116,0.98 [0.63-1.50],0.909753384340003
CEBPB,CCAAT/enhancer-binding protein beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,21758,253,1.05 [0.78-1.40],0.7509494869023594
CEBPB,CCAAT/enhancer-binding protein beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,21758,253,1.05 [0.78-1.40],0.7509494869023594
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),19564,503,1.29 [1.06-1.57],0.0100558210302924
CEBPB,CCAAT/enhancer-binding protein beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,22766,38,1.26 [0.62-2.57],0.5236956418401124
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,23025,58,2.05 [1.31-3.22],0.0017391727057078
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,18237,1421,1.04 [0.91-1.18],0.5986116090337852
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,22569,177,1.12 [0.80-1.56],0.5028811667081892
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes,20550,147,1.11 [0.76-1.60],0.5927927738425938
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Peripheral artery disease,21938,162,1.07 [0.74-1.53],0.728581360789097
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,20535,132,1.06 [0.72-1.57],0.7724479165243623
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes,21085,682,1.03 [0.86-1.24],0.7666231018168652
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,21059,656,1.05 [0.87-1.27],0.594232087533169
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,21560,169,1.01 [0.68-1.49],0.9621313277996204
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",21560,168,1.02 [0.69-1.51],0.924782285515284
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,18084,1268,1.02 [0.89-1.17],0.7759336323719668
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",16995,179,0.99 [0.70-1.40],0.9367515207217814
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,17984,1168,1.01 [0.88-1.16],0.8943856486337174
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,16864,48,1.21 [0.66-2.24],0.5376845963013248
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",16915,99,1.14 [0.73-1.78],0.5648836890885849
CEBPB,CCAAT/enhancer-binding protein beta,Chapter V Mental and behavioural disorders,Any mental disorder,19743,669,1.06 [0.88-1.27],0.5545024388141552
CEBPB,CCAAT/enhancer-binding protein beta,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",19402,328,1.12 [0.87-1.45],0.3885430772551805
CEBPB,CCAAT/enhancer-binding protein beta,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",22721,256,1.06 [0.79-1.42],0.6792917061177721
CEBPB,CCAAT/enhancer-binding protein beta,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",22812,197,1.22 [0.89-1.69],0.2218306771979233
CEBPB,CCAAT/enhancer-binding protein beta,Chapter V Mental and behavioural disorders,Acute alcohol intoxication,21216,76,0.95 [0.56-1.62],0.8493821749232618
CEBPB,CCAAT/enhancer-binding protein beta,Chapter V Mental and behavioural disorders,"Acute alcohol intoxication, ICD10",23136,76,0.95 [0.56-1.62],0.8646860532709371
CEBPB,CCAAT/enhancer-binding protein beta,Chapter V Mental and behavioural disorders,"Alcohol abuse, main dg, excluding more controls",19150,76,0.94 [0.55-1.60],0.8211574121007863
CEBPB,CCAAT/enhancer-binding protein beta,Chapter V Mental and behavioural disorders,Alcohol dependence,21253,113,1.26 [0.83-1.90],0.2762712172551977
CEBPB,CCAAT/enhancer-binding protein beta,Chapter V Mental and behavioural disorders,Smoking dependency,21254,79,1.67 [1.07-2.60],0.0232162812071354
CEBPB,CCAAT/enhancer-binding protein beta,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",19139,65,0.74 [0.40-1.36],0.3297237076589751
CEBPB,CCAAT/enhancer-binding protein beta,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",19336,262,0.90 [0.67-1.20],0.4654503988269931
CEBPB,CCAAT/enhancer-binding protein beta,Chapter V Mental and behavioural disorders,Depression,22113,224,0.96 [0.70-1.31],0.7813015232565452
CEBPB,CCAAT/enhancer-binding protein beta,Chapter V Mental and behavioural disorders,Depression or dysthymia,19055,191,0.97 [0.69-1.36],0.8696461195762426
CEBPB,CCAAT/enhancer-binding protein beta,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",19178,104,0.95 [0.60-1.49],0.8187443453883541
CEBPB,CCAAT/enhancer-binding protein beta,Chapter V Mental and behavioural disorders,Other anxiety disorders,22299,56,0.85 [0.45-1.61],0.623471973459941
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Neurological diseases,19702,1293,0.95 [0.83-1.09],0.4658136071081437
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,17730,80,1.11 [0.67-1.85],0.6869315208365954
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,23184,57,1.04 [0.57-1.90],0.8983583830640077
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,21962,533,0.95 [0.77-1.16],0.6034882943912994
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Epilepsy,21591,162,0.51 [0.34-0.76],0.0009340075330261
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Migraine,21462,33,1.33 [0.63-2.78],0.4554231617480416
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",23125,27,1.40 [0.64-3.07],0.4058764265858038
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Transient ischemic attack,22340,97,0.95 [0.59-1.53],0.8236250394027054
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Other sleep disorders,21664,235,1.32 [0.99-1.74],0.0552573701594215
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Sleep apnoea,22554,184,1.33 [0.97-1.82],0.0750880040224071
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",22346,467,0.89 [0.72-1.12],0.322464424755879
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",21996,117,0.73 [0.47-1.15],0.175695274326202
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,22101,222,0.97 [0.71-1.33],0.8581396130817829
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,22946,86,0.76 [0.45-1.28],0.3034041704449108
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Hemiplegia,22915,55,0.95 [0.51-1.78],0.8747413820059851
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Other neurological diseases,22793,116,1.20 [0.80-1.82],0.3815328256805529
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",22703,299,1.03 [0.79-1.34],0.8207379021139692
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,22576,172,0.99 [0.70-1.40],0.9469463430100792
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,22479,75,0.92 [0.54-1.58],0.7672428560137022
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,22506,102,0.89 [0.56-1.42],0.6286875977079412
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,22453,49,1.43 [0.80-2.54],0.2232857647731585
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,20341,137,0.88 [0.59-1.32],0.5362959840224614
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,20584,380,0.97 [0.76-1.23],0.7935925286531786
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,22329,243,0.85 [0.62-1.15],0.2822426976922503
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,22880,70,1.01 [0.58-1.74],0.9792911215385768
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic maculopathy,2545,70,0.87 [0.49-1.54],0.6267746232327174
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",20405,70,0.98 [0.57-1.71],0.9552757544241458
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,22633,97,1.74 [1.20-2.53],0.0037178157886388
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,22587,51,1.82 [1.10-3.01],0.0201378555357654
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",22747,75,1.06 [0.62-1.80],0.827999558824674
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,22770,92,1.06 [0.66-1.71],0.7988192261665342
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diseases of middle ear and mastoid,23188,129,1.13 [0.76-1.67],0.5485087429835076
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of ear,22347,97,0.83 [0.51-1.35],0.45385228880925
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,15714,3695,1.03 [0.93-1.13],0.5618592188871068
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,22599,61,1.13 [0.64-1.99],0.6835795370616655
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Hypertension, essential",16578,2415,1.02 [0.91-1.14],0.7432697044114456
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Hypertension,16624,2461,1.02 [0.92-1.14],0.6684976130145974
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,14269,106,1.35 [0.88-2.06],0.1664329715789152
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",20608,1640,1.09 [0.97-1.23],0.1484674360702184
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Angina pectoris,19889,921,1.03 [0.88-1.20],0.7466239422370777
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,21874,332,0.97 [0.75-1.25],0.786688154100062
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,22262,720,1.06 [0.89-1.26],0.5308966677429953
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",23086,160,1.15 [0.81-1.65],0.4301189450616399
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",19459,491,1.03 [0.84-1.27],0.770324396505309
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,20343,1399,1.13 [0.99-1.28],0.069677773868357
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Pulmonary embolism,22425,120,1.53 [1.06-2.21],0.0218673942593091
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Venous thromboembolism,22535,238,1.20 [0.90-1.59],0.2182197758445925
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Secondary right heart disease,22388,83,1.49 [0.96-2.32],0.0767943933836301
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,22390,85,1.50 [0.97-2.32],0.0678466033222204
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",14242,79,1.47 [0.93-2.33],0.1018540627916929
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Cardiomyopathy,18218,77,1.77 [1.17-2.67],0.0064335975027897
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Conduction disorders,18308,167,1.17 [0.84-1.65],0.3526402512714511
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,11510,134,1.40 [0.96-2.05],0.0792461182836048
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,11970,594,1.11 [0.90-1.36],0.3420913414582798
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Other arrhythmias,18227,86,0.75 [0.44-1.27],0.2812008733909329
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,18268,127,1.20 [0.82-1.76],0.3459789744367096
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Heart failure, strict",22013,310,1.17 [0.90-1.51],0.233339822690595
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",22285,184,0.89 [0.62-1.26],0.5008020602951966
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",22307,167,1.05 [0.74-1.50],0.7821110904975004
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",22391,148,0.99 [0.68-1.46],0.968705674940056
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,21907,84,0.88 [0.53-1.49],0.6439040488902275
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,21968,145,1.07 [0.72-1.57],0.7444859235755551
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),21977,148,0.98 [0.67-1.43],0.916688613857441
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,DVT of lower extremities,21960,131,1.03 [0.69-1.53],0.8769755940092624
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",23054,123,1.07 [0.71-1.60],0.7577021252920422
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Varicose veins,22164,335,0.97 [0.75-1.25],0.8074935357256874
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Hypotension,22043,80,0.81 [0.47-1.40],0.4549749337654749
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,18150,1977,1.06 [0.95-1.18],0.3088009237304379
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,23119,85,1.04 [0.64-1.71],0.8705490122943146
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Influenza and pneumonia,21202,241,1.08 [0.81-1.45],0.5974298331337413
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",21167,206,1.19 [0.87-1.61],0.2719974818270712
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,22320,272,1.33 [1.02-1.73],0.0322138215835301
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,22317,269,1.35 [1.04-1.76],0.0249718086690248
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,22449,650,0.90 [0.75-1.09],0.27484747949403
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Chronic sinusitis,21869,70,0.60 [0.33-1.09],0.0916111210734814
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Nasal polyp,21963,164,0.93 [0.64-1.34],0.6964638743436635
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",22228,429,0.90 [0.72-1.13],0.377133450728491
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Deviated nasal septum,22027,228,0.88 [0.64-1.20],0.4194631802077124
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,10096,62,1.17 [0.68-2.03],0.5709160253738532
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,20810,838,1.07 [0.91-1.26],0.3983526102831327
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Early onset COPD,21992,191,1.26 [0.91-1.73],0.158399211303138
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",22025,224,1.27 [0.95-1.71],0.1088518724848518
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,"Other chronic obstructive pulmonary disease, including avohilmo",22025,224,1.27 [0.95-1.71],0.1088518724848518
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,"Asthma, hospital admissions , main diagnosis only",21902,652,1.01 [0.84-1.21],0.9183025466709008
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Asthma,15827,652,1.03 [0.86-1.24],0.7372516370170881
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",15496,652,1.03 [0.86-1.24],0.7408933159995457
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",15817,642,1.03 [0.86-1.24],0.7375567924355555
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,22869,100,1.82 [1.26-2.63],0.0015454700222602
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Interstitial lung disease,22141,78,1.93 [1.29-2.90],0.0014411609093145
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,"ILD, hospital admissions",22944,78,1.93 [1.29-2.90],0.0014341017355881
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,22134,71,1.87 [1.21-2.89],0.0048398102039293
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Pleural effusion,21005,134,1.05 [0.71-1.56],0.8044324457573092
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Other diseases of pleura,21155,284,1.17 [0.90-1.52],0.2393272399091007
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,21942,126,1.51 [1.06-2.14],0.0209261052769895
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,15488,5479,0.98 [0.90-1.06],0.5975400639004824
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",22802,358,0.94 [0.74-1.21],0.6421938573917862
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,23253,77,1.18 [0.71-1.95],0.5292416853546513
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Impacted teeth,23256,74,1.17 [0.70-1.96],0.5569303985476857
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Dental caries,22553,109,1.22 [0.80-1.84],0.3531103515751063
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,22522,78,0.41 [0.23-0.74],0.002867866625075
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,23244,86,1.06 [0.65-1.74],0.808141312372021
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,22521,77,0.71 [0.41-1.25],0.232461048274485
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,22292,77,0.78 [0.45-1.36],0.3810530931875514
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,23186,55,0.76 [0.39-1.45],0.4017199272233741
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,17839,315,1.21 [0.94-1.55],0.140734860532853
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",19480,1956,0.94 [0.85-1.06],0.3169308607138584
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Oesophagitis,17902,378,0.79 [0.62-1.01],0.0644143745989307
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,18151,627,1.01 [0.84-1.22],0.9126205425088704
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,17596,72,1.01 [0.58-1.74],0.979498081095518
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,17798,274,0.93 [0.70-1.24],0.630395670581106
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Oesophageal obstruction,17598,74,1.13 [0.67-1.90],0.6562360668613516
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Gastric ulcer,17678,154,0.95 [0.65-1.38],0.7828418387716726
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Duodenal ulcer,17692,168,1.49 [1.09-2.03],0.012415359067802
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",23095,116,1.76 [1.25-2.50],0.0013244290162255
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Chronic gastritis,17632,108,0.94 [0.60-1.48],0.7918174241377249
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),18289,765,0.92 [0.77-1.09],0.3184730825980709
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Diseases of appendix,23130,102,0.64 [0.39-1.04],0.0713717221931247
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Functional dyspepsia,17811,287,0.99 [0.75-1.29],0.9167588890037612
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,17679,155,0.69 [0.47-1.03],0.0680924270022353
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,23089,164,1.34 [0.97-1.86],0.0803798624387309
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Acute appendicitis,23110,82,0.48 [0.28-0.85],0.0114142986955338
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Hernia,19828,2007,0.93 [0.83-1.04],0.1820867656340593
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Inguinal hernia,18921,1100,0.87 [0.75-1.01],0.07175657791685
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Umbilical hernia,18005,184,1.01 [0.72-1.41],0.9638514081182282
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Ventral hernia,17914,93,1.36 [0.89-2.09],0.1576290629544291
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,18571,750,0.93 [0.78-1.11],0.4162301841482964
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,22426,585,1.13 [0.94-1.36],0.1999160911540722
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other diseases of intestines,17974,1775,1.10 [0.98-1.23],0.1006328325415885
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",22950,54,1.57 [0.92-2.67],0.0946486753644193
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, require KELA, min 2 HDR)",23210,70,1.40 [0.85-2.30],0.1830979387705448
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Crohn disease,21911,70,1.40 [0.85-2.30],0.1837951667455974
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Crohn's disease NAS,21896,55,1.46 [0.84-2.53],0.1757812483453101
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,"Ulcerative colitis (strict definition, require KELA, min 2 HDR)",23154,139,1.46 [1.02-2.07],0.0359754307264086
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Ulcerative colitis,21980,139,1.46 [1.02-2.07],0.0365070936605269
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",21966,125,1.59 [1.12-2.27],0.0099606401632924
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,22280,439,1.03 [0.82-1.28],0.8100992684630848
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,22277,436,1.03 [0.83-1.29],0.7856635598187736
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,16287,88,1.39 [0.89-2.14],0.1437224569884105
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Intestinal stricture,22832,88,1.42 [0.91-2.21],0.1225258085546829
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",16261,62,1.70 [1.07-2.71],0.0252353772793383
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,16728,529,1.21 [1.00-1.47],0.0495784923701527
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,16284,85,0.63 [0.37-1.08],0.0913682318368116
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,16377,178,1.21 [0.88-1.68],0.2390958036274021
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Constipation,21739,162,1.28 [0.91-1.79],0.1532297942797514
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Diseases of peritoneum,22910,47,1.10 [0.56-2.13],0.7865817411726148
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,16356,157,1.25 [0.89-1.76],0.1995480655891903
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,16293,94,1.17 [0.75-1.84],0.4867165347809675
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,17047,848,0.98 [0.84-1.16],0.8544817267575726
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other diseases of intestine,16507,308,1.22 [0.95-1.55],0.1142903192368958
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,22900,37,1.32 [0.65-2.67],0.4423082393410877
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Diseases of liver,22457,141,1.15 [0.79-1.68],0.4558159509742655
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other diseases of liver,22399,83,0.93 [0.56-1.56],0.796229289659232
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",22136,359,1.28 [1.02-1.61],0.0356776538331749
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Cholelithiasis,22039,262,1.31 [1.01-1.71],0.0427903027084864
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Cholecystitis,21843,66,1.62 [1.00-2.63],0.0506876037970014
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,21808,31,1.96 [1.05-3.65],0.0337339450458263
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Acute pancreatitis,21847,70,1.17 [0.69-2.01],0.5571330207765077
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Acute pancreatitis (for exclusion),23088,70,1.17 [0.69-1.98],0.5695469228277178
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Diseases of the digestive system,21933,310,1.27 [0.99-1.62],0.0595455681547719
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Intestinal malabsorption,21661,38,0.78 [0.35-1.72],0.5365255198290174
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Coeliac disease,21651,28,1.00 [0.41-2.41],0.9952490827188144
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",21680,57,1.36 [0.78-2.37],0.2849875148657494
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,21844,221,1.28 [0.96-1.71],0.0922687726132995
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,GI-bleeding,21840,217,1.28 [0.95-1.71],0.09871099586696
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,20198,1452,0.97 [0.86-1.10],0.6849772436838418
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,22834,89,1.28 [0.82-2.00],0.2846209261178678
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,22899,440,0.92 [0.73-1.15],0.4425359594541175
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,21688,442,0.93 [0.74-1.16],0.5029489998945644
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,22308,460,0.92 [0.74-1.15],0.4765720705879707
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",21954,106,0.80 [0.50-1.28],0.3582406517808454
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,22145,297,0.89 [0.68-1.18],0.4270512241176719
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,23011,89,1.12 [0.70-1.79],0.6415557069546949
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,22996,74,1.15 [0.69-1.91],0.6025441217018863
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,22977,55,1.07 [0.59-1.95],0.8280392574885166
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,22970,56,nan [nan-nan],
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,22968,54,nan [nan-nan],
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,22515,56,0.70 [0.37-1.35],0.2933624184105377
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,22816,357,0.92 [0.71-1.18],0.4900049837541129
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,21330,84,0.97 [0.58-1.61],0.9095627909407008
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,21288,42,0.80 [0.38-1.68],0.55026151403584
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,21283,37,0.74 [0.33-1.66],0.4666697289799327
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",21419,173,1.06 [0.75-1.49],0.7561209679603801
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,21397,151,1.02 [0.71-1.48],0.904183567110434
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,17165,3473,0.94 [0.85-1.02],0.149555348756366
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,18615,2041,0.92 [0.82-1.03],0.1460358310427255
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,21081,1056,0.84 [0.72-0.97],0.021549142566519
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,16662,88,1.12 [0.70-1.82],0.6322053800901565
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,16977,403,1.05 [0.83-1.32],0.7044349034691217
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",23016,85,1.05 [0.64-1.73],0.8498443149309655
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,23021,75,1.02 [0.60-1.73],0.9465462607859548
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,17618,1044,0.91 [0.78-1.06],0.2284607007893684
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Artrosis, including avohilmo",20008,1044,0.92 [0.79-1.06],0.2484060880266794
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,16701,127,0.87 [0.57-1.33],0.5306580497048969
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",22337,123,0.96 [0.63-1.45],0.832063212237351
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,16736,162,1.13 [0.80-1.61],0.4832821877871447
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,16630,56,0.84 [0.45-1.57],0.5774138719883802
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,16829,255,0.97 [0.73-1.30],0.8519004644660927
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",23158,122,0.97 [0.64-1.48],0.8903600049295193
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,17132,558,0.89 [0.73-1.10],0.2815328598297615
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,16870,296,0.79 [0.59-1.04],0.0969748433433219
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,17697,1123,0.88 [0.76-1.02],0.0854382632748331
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),16595,21,0.58 [0.19-1.76],0.3383149759759749
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),16619,45,1.03 [0.52-2.03],0.9400827510148922
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,16602,28,0.54 [0.21-1.39],0.2005734486195315
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),16589,15,1.09 [0.34-3.52],0.8803542602678811
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,17154,580,0.85 [0.69-1.04],0.1090355927664011
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,17081,507,0.85 [0.68-1.05],0.1267992865319572
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,18792,254,0.83 [0.62-1.13],0.2346543300330482
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,22998,33,0.69 [0.29-1.63],0.39513397852653
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,22982,17,1.15 [0.37-3.54],0.8105109980174091
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,20328,42,0.56 [0.26-1.22],0.145358401991154
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,20563,277,0.89 [0.67-1.18],0.4152320333496049
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,21096,810,0.99 [0.84-1.16],0.8701501585750373
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,20444,158,1.04 [0.73-1.49],0.8270852416099992
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,20374,88,0.64 [0.38-1.09],0.098180224320813
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",20916,630,1.02 [0.85-1.22],0.8605761918864202
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,20334,48,1.09 [0.57-2.09],0.802273519864664
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,20503,217,0.93 [0.68-1.28],0.6742292664969489
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,20380,94,0.86 [0.53-1.41],0.5532234893957643
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,20350,64,0.82 [0.45-1.48],0.5037928605052114
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,20401,115,0.83 [0.53-1.30],0.41208742541906
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,20336,50,1.12 [0.60-2.09],0.7142898047616584
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,20544,258,1.14 [0.86-1.51],0.3502717183388181
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,20259,234,0.76 [0.55-1.04],0.0879967405151244
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,20089,64,1.16 [0.67-2.02],0.5961590833716892
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,20086,61,0.71 [0.38-1.32],0.2824667744832553
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,20085,60,0.86 [0.46-1.58],0.6174057422277748
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",20084,59,1.17 [0.67-2.06],0.5770271128801756
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,20195,170,1.01 [0.70-1.44],0.9736073500041524
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],20184,159,1.16 [0.82-1.66],0.4026715954717699
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,20270,245,0.91 [0.67-1.23],0.5466565337779181
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,20074,49,1.25 [0.69-2.27],0.4652307833300678
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,20112,87,1.01 [0.61-1.65],0.9778568641667345
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,20136,111,0.69 [0.43-1.10],0.123428098757297
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,20066,41,0.45 [0.20-0.99],0.0462996047019158
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",20365,340,0.71 [0.54-0.92],0.0112956927730673
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,20160,135,0.68 [0.44-1.03],0.0701316796530993
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,20210,185,0.67 [0.47-0.96],0.0307874754606663
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,22267,102,1.34 [0.89-2.01],0.1644530782284654
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,22453,288,1.14 [0.87-1.48],0.3383603278831446
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,22220,55,1.23 [0.68-2.22],0.4949495591541003
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,22216,51,0.73 [0.37-1.46],0.371394737524517
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,22254,89,0.82 [0.49-1.36],0.4468606061461532
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,17844,2333,1.10 [0.99-1.22],0.0680946890819476
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,20049,1262,1.02 [0.89-1.17],0.7504806053738888
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,20524,298,1.70 [1.36-2.13],3.9025574359460185e-06
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,20316,90,1.63 [1.07-2.49],0.0242763256253586
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Acute renal failure,20557,73,2.05 [1.38-3.05],0.0003526377717643
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,20573,89,1.46 [0.94-2.27],0.0922045554039513
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,20574,90,1.87 [1.27-2.74],0.0014692721989124
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Urolithiasis,22786,352,1.29 [1.02-1.62],0.0306801087756846
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,22753,77,1.08 [0.65-1.82],0.7573179570473751
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,22679,245,1.25 [0.94-1.65],0.1186224434628822
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,22570,136,1.31 [0.91-1.88],0.1425714199772788
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,21108,820,1.08 [0.92-1.27],0.3590213775699767
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Cystitis,20348,60,1.33 [0.76-2.32],0.3189028116325151
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,20361,73,0.87 [0.49-1.53],0.6279545917105547
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,20661,373,1.03 [0.81-1.31],0.8178846675616587
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Urethral stricture,20429,141,1.01 [0.68-1.49],0.9534900960904836
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,20651,363,1.18 [0.93-1.49],0.1769343125725362
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,19348,561,1.12 [0.92-1.36],0.253966032770782
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),18891,104,0.87 [0.55-1.39],0.5683153700748734
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Hydrocele,18883,96,0.96 [0.60-1.54],0.8615373483266172
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",18947,160,1.08 [0.75-1.55],0.6751657750307234
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,18945,158,1.06 [0.73-1.52],0.7640502973809207
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,19001,214,0.92 [0.67-1.28],0.6266392105693614
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",22770,76,1.10 [0.66-1.85],0.715803337370287
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Falls/tendency to fall,21135,538,1.01 [0.83-1.23],0.927853938961588
